BARR Kenneth Jay,MACLEAN John,ZHANG Hongjun,BERESIS Richard Thomas,ANTHONY Neville,DANIELS Matthew H,LAPOINTE Blair,SCIAMMETTA Nunzio
申请号：
SI201331469
公开号：
SI2920149T1
申请日:
2013.08.14
申请国别(地区):
SI
年份:
2019
代理人:
摘要：
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
